WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that the Company’s President and Chief Executive Officer, Tod Woolf, Ph.D., will present a corporate overview at the Rodman & Renshaw Global Investment Conference on Friday, September 11, 2009 at 11:15am ET, at the New York Palace Hotel in New York City.
